Key result
Global deaths from hypertensive heart disease increased from 0.66 million in 1990 to 1.16 million in 2019, though the observed higher mortality in women in lower SDI countries may reflect survival bias.
Answers are grounded in this paper and cite their sources.
The apparent higher burden of hypertensive heart disease mortality among women in lower SDI countries may be influenced by survival bias, highlighting the importance of equitable hypertension management for both sexes.
This editorial refers to ‘Worldwide trends in mortality for hypertensive heart disease from 1990 to 2019 with projection to 2034: an age-period-cohort analysis for the Global Burden of Disease 2019 study’, by W. L. Lu et al. https://doi.org/10.1093/eurjpc/zwad262. According to Global Burden of Disease (GBD) estimates, hypertension, specifically high systolic blood pressure, was the leading risk factor for attributable deaths, accounting for 10.8 million deaths globally in 2019.1 As one of the main consequences of long-standing hypertension due to increased workload of the heart, hypertensive heart disease (HHD) constitutes a constellation of structural and functional abnormalities, characterized most notably by left ventricle hypertrophy (LVH). Hypertensive heart disease can progress into heart failure (HF) and cardiac arrhythmias, which typically onset at older ages compared to other types of cardiovascular disease (CVD) such as ischaemic heart disease (IHD). Given the significance of hypertension as a leading modifiable risk factor, Lu et al.2 are to be commended for their thorough investigation into the trends in mortality for HHD based on GBD data from 204 countries. The main findings by Lu et al. can be summarized as follows: Globally, between 1990 and 2019, the number of HHD deaths increased from 0.66 [95% confidence interval (CI) 0.53–0.73] to 1.16 (95% CI 0.86–1.28) million and is expected to reach 1.57 million in 2034. Middle sociodemographic index (SDI) countries such as Brazil, China, and Indonesia accounted for the largest share of HHD deaths at 37.5% but also the largest decrease in age-standardized mortality rates (ASMRs) for HHD, with an annual percentage change of −2.06%. Additionally, Lu et al. observed higher ASMRs for HHD in women than in men in lower SDI countries, suggesting that in these countries, women have a larger HHD burden than men do. Taken together, the findings suggest that strengthening access to hypertension control and management for elderly women in lower SDI countries is warranted. From a public health perspective, reducing hypertension is one of the key global targets set forth by the World Health Organization for improving population health, and the present findings are consistent with this effort. On the other hand, considering that men generally lead a less favourable lifestyle,3 suffer more IHD than women,3 and have a substantially higher prevalence of LVH,4 the observed female predominance of HHD mortality might actually be driven by survival bias (selection bias from conditioning on survival) giving rise to the observed crossing over of CVD mortality,5 as explained in the following paragraph. The phenomenon of mortality crossover describes the paradoxical convergence and crossover of mortality rates among population subgroups with distinct differences in the underlying drivers of health, such as sex, race, or socioeconomic status.6 Specifically, the phenomenon of mortality crossover refers to the observation that at younger ages, the rate of all-cause or cause-specific mortality is higher in population Subgroup A than in Subgroup B. However, with increasing age, the mortality gap between these subgroups begins to converge and at old age, the mortality rate then becomes higher in population Subgroup B than in Subgroup A, hence the term ‘crossover’. Two major hypotheses have been proposed to explain this phenomenon. The first is age overstatement resulting in underestimated mortality rates,6 but correcting the data does not eliminate the crossover. The second explanation is mortality selection,7 which suggests that in the population subgroup experiencing greater survival pressure, fewer frail members of the underlying birth cohorts survive to old age. Consequently, only those who are more robust and resistant to disease can survive to old age. However, at least for hypertension, contrary to observational evidence showing no link between hypertension and mortality among those aged 80 years or above, in the same age group the Systolic Blood Pressure Intervention Trial demonstrated that intensive blood pressure reduction, regardless of gait speed indicating frailty, significantly reduced cardiovascular events, and all-cause mortality.8 This suggests that selection by frailty alone is insufficient to explain mortality crossover. Analytically, another consequence of mortality selection in observational studies is survival bias, which could potentially explain the observed converging mortality gap between population subgroups with persistent differences in the underlying drivers of health.9 Intuitively, a person exposed to more harmful risk factors is more likely to die at a younger age than someone exposed to fewer risk factors. Therefore, in the group selected more adversely by mortality, older individuals are therefore more selected on attributes that promote longevity, such as lifetime smoking abstinence. When these attributes influence not only longevity but also the outcome of interest, survival bias may give rise to the observed convergence and crossover of mortality gap due to spurious associations via these common causes of longevity and outcome. For the reasons discussed above, when interpreting the observation that women in lower SDI countries have a larger HHD burden than men, several cautions must be mentioned. First, in comparison to higher SDI countries, a higher proportion of men than women die prematurely from CVD in lower SDI countries,3 suggesting that bias due to selective survival of CVD might be more apparent in men in these regions. Second, in addition to hypertension, other risk factors such as obesity and tobacco smoking can also contribute to the development of HHD,10 implying that survival bias could operate via these risk factors. Third, deaths resulting from HHD progressing into HF or cardiac arrhythmias tend to occur at older ages,1 so the impact of survival bias might be more pronounced than if these deaths were to occur at younger ages. Considering the possibility of survival bias contributing to the observed female predominance of HHD mortality in lower SDI countries, the wide mortality gap by sex might be more apparent than real. Since it is unlikely that men become more resistant to HHD than women with age, in addition to ensuring equitable access to preventive and treatment services for women, strengthening hypertension control for HHD prevention remains an important public health target for men. None. No original data were collected for this article.
No takes yet. Share an insight, caveat, or question.
Io Ieong Chan (2023) conducted an editorial in Hypertensive heart disease. Hypertension was evaluated on Hypertensive heart disease deaths. Global deaths from hypertensive heart disease increased from 0.66 million in 1990 to 1.16 million in 2019, though the observed higher mortality in women in lower SDI countries may reflect survival bias.
Synapse has enriched 10 related papers. Consider them for comparative context: